Physician

Sidarth Dasari

According to 2025 Medicare claims, Sidarth Dasari (NPI: 1497286421) practices neurology in the Fort Collins-Loveland, CO market, with the plurality of this provider's patient population coming from Larimer, CO. This provider's primary affiliated billing organization is ADVANCED NEUROLOGY OF COLORADO, LLC (NPI: 1972556991; TIN: 680562419) and primary practice location at 80528-3401. Dasari is affiliated with the Aledade 159 CO MSSP Enhanced (ACO ID: A5362), participating under the MSSP model.

Dasari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 251 traditional Medicare patients, billed 6,031 HCPCS/CPT codes, and received $163,862 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 790 prescription claims across 230 beneficiaries totaling $373,385 in drug costs, led by Qulipta (Atogepant). Open Payments data shows 246 records totaling $157,824. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,308 to $373,385. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	97	147	$12,155
2022	203	1,066	$30,650
2023	299	4,787	$91,702
2024	251	6,031	$163,862

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	28	79	$4,308
2018	34	87	$57,379
2019	38	160	$181,523
2020	37	147	$184,014
2021	78	331	$298,490
2022	130	565	$911,443
2023	155	637	$269,902
2024	230	790	$373,385

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	46	46	$157
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	41	41	$124
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	75	84	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	92	121	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	33	36	$47

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Qulipta	Atogepant	21	870	$30,505
Ubrelvy	Ubrogepant	17	464	$18,322
Nurtec Odt	Rimegepant Sulfate	14	255	$15,660
Emgality Pen	Galcanezumab-Gnlm	12	534	$12,252
Ajovy Autoinjector	Fremanezumab-Vfrm	16	468	$10,781

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	241	$8,793	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$149,031	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sidarth Dasari?

Tedicare shows public-source Medicare data for Sidarth Dasari (NPI 1497286421), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sidarth Dasari have ACO affiliation data?

Sidarth Dasari is shown with ACO affiliation data for Aledade 159 CO MSSP Enhanced (MSSP, ACO ID A5362).

What billing organization is linked to Sidarth Dasari?

Sidarth Dasari is linked to ADVANCED NEUROLOGY OF COLORADO, LLC (billing NPI 1972556991) in the available physician profile data.

Does Sidarth Dasari have Open Payments data?

Sidarth Dasari has 246 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.